Tryptase as a marker of severity of aortic valve stenosis
Abstract Background Severe aortic valve stenosis is one of the most common cause of mortality in adult patients affected with metabolic syndrome, a condition associated with an active inflammatory process involving also mast cells and their mediators, in particular tryptase. The aim of this study wa...
Main Authors: | Laura M. Losappio, Corrado Mirone, Michel Chevallard, Laura Farioli, Fabrizio De Luca, Elide A. Pastorello |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Clinical and Molecular Allergy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12948-018-0095-6 |
Similar Items
-
Will Transcatheter Aortic Valve Replacement (TAVR) be the Primary Therapy for Aortic Stenosis?
by: Jose F. Condado, MD, MS, et al.
Published: (2016-05-01) -
Transcatheter aortic valve implantation vs surgical aortic valve replacement in high-risk patients with aortic stenosis
by: Emad Sarawy
Published: (2020-01-01) -
Beating aortic valve replacement surgery as an alternative to transcatheter aortic valve implantation in a patient with severe aortic stenosis and left ventricular dysfunction
by: Kenji Iino, et al.
Published: (2018-12-01) -
Aortic Valve Replacement for Aortic Stenosis in Elderly Patients (75 Years or Older)
by: Bongyeon Sohn, et al.
Published: (2018-10-01) -
Transcatheter aortic valve implantation – new era in treatment of aortic stenosis
by: Oleg Calenici
Published: (2020-03-01)